Quarterly Results Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
238.50
233.10
222.40
210.09
202.71
195.02
187.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
238.50
233.10
222.40
210.09
202.71
195.02
187.00
Raw Material Cost
145.46
134.93
144.29
125.45
115.10
134.51
127.55
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
1.59
8.58
-7.34
4.28
10.10
-13.68
-11.12
Employee Cost
41.37
42.05
36.45
32.23
31.93
32.17
30.97
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
-0.01
0.00
0.00
-0.01
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
24.79
23.17
20.44
21.60
20.03
17.39
16.55
Total Expenditure (Excl Depreciation)
213.21
208.72
193.84
183.56
177.15
170.39
163.95
Operating Profit (PBDIT) excl Other Income
25.29
24.38
28.56
26.53
25.56
24.63
23.05
Other Income
4.35
4.57
3.65
5.24
4.94
4.11
4.84
Operating Profit (PBDIT)
29.64
28.95
32.21
31.77
30.50
28.74
27.89
Interest
1.48
1.28
1.02
1.06
1.33
1.46
1.10
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
28.16
27.67
31.19
30.71
29.17
27.28
26.79
Depreciation
8.00
7.70
7.60
7.45
8.34
6.94
6.50
Profit Before Tax
20.16
19.97
23.59
23.26
20.82
20.34
20.29
Tax
4.17
4.97
5.79
5.59
4.54
4.76
4.63
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
15.99
15.00
17.80
17.66
16.28
15.58
15.66
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
15.99
15.00
17.80
17.66
16.28
15.58
15.66
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
15.99
15.00
17.80
17.66
16.28
15.58
15.66
Equity Capital
10.55
10.54
10.54
10.48
10.48
10.45
10.45
Face Value
5.0
5.0
5.0
5.0
5.0
5.0
5.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
7.58
7.12
8.44
8.43
7.77
7.45
7.49
Diluted Earnings per share
7.49
7.05
8.4
8.34
7.69
7.38
7.43
Operating Profit Margin (Excl OI)
10.6%
10.46%
12.84%
12.63%
12.61%
12.63%
12.33%
Gross Profit Margin
11.81%
11.87%
14.02%
14.62%
14.39%
13.99%
14.33%
PAT Margin
6.7%
6.44%
8.0%
8.41%
8.03%
7.99%
8.37%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is 2.32% vs 4.81% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 6.60% vs -15.73% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is 3.73% vs -14.64% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is 15.62% vs 25.49% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
Compare Quarterly Results Of Windlas Biotech With
Figures in Cr
Consolidate Quarterly Results
Change(INR)
Change(%)
Net Sales
238.50
100.11
138.39
138.24%
Other Operating Income
0.00
0.00
0.00
Total Operating income
238.50
100.11
138.39
138.24%
Raw Material Cost
145.46
21.30
124.16
582.91%
Purchase of Finished goods
0.00
5.65
-5.65
-100.00%
(Increase) / Decrease In Stocks
1.59
-7.50
9.09
121.20%
Employee Cost
41.37
16.37
25.00
152.72%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
24.79
29.96
-5.17
-17.26%
Total Expenditure (Excl Depreciation)
213.21
65.78
147.43
224.13%
Operating Profit (PBDIT) excl Other Income
25.29
34.33
-9.04
-26.33%
Other Income
4.35
-3.03
7.38
243.56%
Operating Profit (PBDIT)
29.64
31.30
-1.66
-5.30%
Interest
1.48
5.10
-3.62
-70.98%
Exceptional Items
0.00
2.94
-2.94
-100.00%
Gross Profit (PBDT)
28.16
29.14
-0.98
-3.36%
Depreciation
8.00
5.91
2.09
35.36%
Profit Before Tax
20.16
25.09
-4.93
-19.65%
Tax
4.17
8.54
-4.37
-51.17%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
15.99
14.69
1.30
8.85%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
15.99
14.69
1.30
8.85%
Share in Profit of Associates
0.00
1.86
-1.86
-100.00%
Minority Interest
0.00
0.56
-0.56
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
15.99
15.98
0.01
0.06%
Equity Capital
10.55
8.51
2.04
23.97%
Face Value
5.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
7.58
18.78
-11.20
-59.64%
Diluted Earnings per share
7.49
19.45
-11.96
-61.49%
Operating Profit Margin (Excl OI)
10.60%
34.29%
0.00
-23.69%
Gross Profit Margin
11.81%
29.11%
0.00
-17.30%
PAT Margin
6.70%
16.53%
0.00
-9.83%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 238.50 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is 2.32% vs 4.81% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 17.66% vs 18.34% in Mar 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 15.99 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is 6.60% vs -15.73% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -1.78% vs -4.18% in Mar 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 25.29 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is 3.73% vs -14.64% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -1.06% vs 16.13% in Mar 2025
Quarterly - Interest
Interest 1.48 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is 15.62% vs 25.49% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 11.28% vs 375.00% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 10.60%
in Mar 2026Figures in %
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025
